Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy: Correlation of radiologic findings with surgicopathologic results

Cancer

Volumn 113, Issue 8, 2008, Pages 2158-2165

  Vincens, Etienne ^a   Balleyguier, Corinne ^a   Rey, Annie ^a   Uzan, Catherine ^a   Zareski, Elise ^a   Gouy, Sebastien ^a   Pautier, Patricia ^a   Duvillard, Pierre ^a   Haie Meder, Christine ^a   Morice, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cervical cancer; Chemoradiation; Completion surgery; Magnetic resonance imaging; Residual disease

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; FALSE POSITIVE RESULT; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM, RESIDUAL; PLATINUM COMPOUNDS; RADIOTHERAPY; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 55749095016     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23817     Document Type: Article

References (27)

1. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
2. Morice P, Uzan C, Zafrani Y, Delpech Y, Gouy S, Haie-Meder C. The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer. Gynecol Oncol. 2007;107:S122-S124.
3. Mariagrazia D, Anna F, Gabriella F, et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: longterm outcome and complications. Gynecol Oncol. 2005;99(suppl 1):S166-S170.
4. Classe JM, Rauch P, Rodier JF, et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome. Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer). Gynecol Oncol. 2006;102:523-529.
5. Azria E, Morice P, Haie-Meder C et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiation therapy for stage IB2/II cervical carcinoma. Ann Surg Oncol. 2005;12:332-337.
6. Houvenaeghel G, Lelievre L, Butarelli M, et al. Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma. Eur J Surg Oncol. 2007;33:498-503.
7. International Commission on Radiation Units and Measurements. Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. ICRU Report 38. Bethesda, Md: ICRU; 1985.
8. Delpech Y, Haie-Meder C, Rey A et al. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma confined radiologically to the pelvic cavity. Ann Surg Oncol. 2007;14:3223-3231.
9. Kinkel K, Ariche M, Tardivon AA, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology. 1997;204:55-63.
10. De Graef M, Karam M, Juhan V, Daclin PY, Maubon AJ, Rounnat JP. High signals in the uterine cervix on T2 weighted MRI sequences. Eur Radiol. 2003;13:118-126.
11. Jeong YY, Kang HK, Chung TW, Seo JJ, Park JG. Uterine cervical carcinoma after therapy: CT and MR imaging findings. Radiographics. 2003;23:969-981.
12. Subak LL, Hricak H, Powell CB, et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol. 1995;6:43-50.
13. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology. 1988;166:623-632.
14. Hawnaur JM, Johnson RJ, Buckley CH, et al. Staging, volume estimation and assessment of nodal status in carcinoma of the cervix: comparison of magnetic resonance imaging with surgical findings. Clin Radiol. 1994;49:443-452.
15. Yamashita Y, Takahashi M, Sawada T, et al. Carcinoma of the cervix: dynamic MR imaging. Radiology. 2002:182:643-648.
16. Bipat S, Glas AS, van der Velden J, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol. 2003;91:59-66.
17. Scheidler J, Heuck AF. Imaging of cancer of the cervix. Radiol Clin North Am. 2002;40:577-590.
18. Hatano K, Sekiya Y, Araki H, et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 1999;45:639-644.
19. Nam H, Park W, Huh SJ, et al. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol. 2007;107:320-325.
20. Mayr NA, Taoka T, Yuh WTC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002;52:14-22.
21. Nijhuis ER, van der Zee AG, in't Hout BA, et al. Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery. Int J Radiat Oncol Biol Phys. 2006;66:699-705.
22. Ohara K, Tanaka YO, Tsunoda H. et al. Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging. Obstet Gynecol. 2002;100:781-787.
23. Ngan HYS, Chan SYW, Wong LC, et al. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol Oncol. 1990;37:260-263.
24. Yoon SM, Shin KH, Kim JY, et al. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy. Int J Gynecol Cancer. 2007;17:872-878.
25. Naganawa S, Sato C, Kumada H, et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol. 2005;15:71-78.
26. Lin LL, Yang Z, Miller TR, et al. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys. 2006;65:177-181.
27. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol. 2008;18:1058-1064.